Changsha Xincaisheng Trading Co., Ltd – Trademark Portfolio

Entity Type: 99

Changsha Xincaisheng Trading Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VEOWOO. The owner is based in Changsha City.

No. 086, Building B1, Hongxing Cold Chain Trading Center, No. 21

Section 1, Huanbao East Road, Tongsheng Subdistrict, Yuhua District

Changsha City 410000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VEOWOO
VEOWOO
Registered 2025

Trademark Classifications

Changsha Xincaisheng Trading Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Changsha Xincaisheng Trading Co., Ltd have?

Changsha Xincaisheng Trading Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Changsha Xincaisheng Trading Co., Ltd file in?

Changsha Xincaisheng Trading Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 14 (Jewelry). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Changsha Xincaisheng Trading Co., Ltd's most well-known trademarks?

Changsha Xincaisheng Trading Co., Ltd's registered trademark portfolio includes well-known marks such as VEOWOO. These are among 1 currently registered trademark in the portfolio.

What is Changsha Xincaisheng Trading Co., Ltd's trademark registration success rate?

Changsha Xincaisheng Trading Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.